Informa plc (LON:INF) Receives GBX 1,105 Average Price Target from Analysts

Shares of Informa plc (LON:INF) have earned an average rating of “Moderate Buy” from the six ratings firms that are covering the company, Marketbeat reports. One analyst has rated the stock with a hold rating and five have given a buy rating to the company. The average 1-year target price among brokerages that have issued ratings on the stock in the last year is GBX 1,105.

INF has been the subject of several analyst reports. JPMorgan Chase & Co. cut their price objective on Informa from GBX 1,345 to GBX 1,330 and set an “overweight” rating on the stock in a research note on Monday. Citigroup initiated coverage on Informa in a research note on Monday. They set a “neutral” rating and a GBX 975 target price for the company. Panmure Gordon reaffirmed a “buy” rating and issued a GBX 1,200 target price on shares of Informa in a report on Wednesday, November 19th. UBS Group reiterated a “buy” rating and set a GBX 1,055 price target on shares of Informa in a report on Friday, November 7th. Finally, Deutsche Bank Aktiengesellschaft increased their price objective on Informa from GBX 1,000 to GBX 1,140 and gave the company a “buy” rating in a research report on Wednesday, October 29th.

Informa Trading Down 0.5%

Shares of Informa stock opened at GBX 889.60 on Monday. Informa has a fifty-two week low of GBX 634.20 and a fifty-two week high of GBX 1,000. The company has a quick ratio of 1.70, a current ratio of 0.56 and a debt-to-equity ratio of 31.98. The firm has a market cap of £11.38 billion, a price-to-earnings ratio of 161.75, a price-to-earnings-growth ratio of 0.75 and a beta of 1.12. The business has a fifty day simple moving average of GBX 912.84 and a 200-day simple moving average of GBX 898.34.

Informa Company Profile

Our events, digital products and academic research services connect specialists with knowledge, helping them learn more, know more and do more.

We do this in dozens of specialist markets and subject matter categories, including in Healthcare & Pharma, Technology, Finance, Education, Marketing, Health & Nutrition, Foodservice, and many more.

And we do this through a range of products and services, including major live events, specialist media and content, expert research articles, books and open research platforms, accredited training, buyer discovery services, and digital demand and lead-generation services.